Harvard Bioscience HBIO SEC Filings

NASDAQ HBIO
$7.90 -0.14 (-1.77%)
As of: Sep 10, 2026 · 9:46 AM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Harvard Bioscience Inc (HBIO) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index